Company intelligence / Profile preview

Beilu Pharmaceutical

Beijing, Beijing, Chinabeilupharma.com ↗

Ownership: Private
Employees: ~1173
Development stage: Commercial

Overview

Beilu Pharmaceutical is a leading Chinese manufacturer of contrast media for diagnostic imaging with a strong commercial presence in China and expanding international markets. Its portfolio includes multiple approved gadolinium-based MRI agents and iodine-based CT/X-ray agents as well as oral anti-diabetic drugs and traditional Chinese medicines[2][5][6].

Therapeutic areas: OtherPsychiatryEndocrinology
Modalities: Small moleculeContrast media (Gadolinium-based and Iodine-based agents)Traditional Chinese medicine
Industry: Biotech

Drug pipeline

2 assets

Jiu-wei-zhen-xiao

1 more asset in the full pipeline.

Request access →

Partnerships

Investment in Geneseeq Technology; no major global pharma partnerships publicly listed

Beyond the preview

Go deeper on Beilu Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beilu Pharmaceutical.

Explore the full profile